Invanz Drug Patent Profile

Which patents cover Invanz, and when can generic versions of Invanz launch?

Invanz is a drug marketed by Msd Sub Merck and is included in one NDA.

The generic ingredient in INVANZ is ertapenem sodium. There are eight drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the ertapenem sodium profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Invanz

A generic version of Invanz was approved as ertapenem sodium by ACS DOBFAR SPA on April 16^th, 2018.

Summary for Invanz

US Patents:	0
Applicants:	1
NDAs:	1
Finished Product Suppliers / Packagers:	2
Raw Ingredient (Bulk) Api Vendors:	58
Clinical Trials:	21
Patent Applications:	5,049
Formulation / Manufacturing:	see details
Drug Prices:	Drug price information for Invanz
What excipients (inactive ingredients) are in Invanz?	Invanz excipients list
DailyMed Link:	Invanz at DailyMed

See drug prices for Invanz

Recent Clinical Trials for Invanz

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Todd C. Lee MD MPH FIDSA	Phase 2
Iterum Therapeutics, International Limited	Phase 3
Iterum Therapeutics, US Limited	Phase 3

See all Invanz clinical trials

Pharmacology for Invanz

Drug Class

Penem Antibacterial

Anatomical Therapeutic Chemical (ATC) Classes for Invanz

J01DH	Carbapenems
J01D	OTHER BETA-LACTAM ANTIBACTERIALS
J01	ANTIBACTERIALS FOR SYSTEMIC USE
J	Antiinfectives for systemic use

Paragraph IV (Patent) Challenges for INVANZ

Tradename	Dosage	Ingredient	Strength	NDA	ANDAs Submitted	Submissiondate
INVANZ	Injection	ertapenem sodium	1 g/vial	021337	1	2012-12-21

US Patents and Regulatory Information for Invanz

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Msd Sub Merck	INVANZ	ertapenem sodium	INJECTABLE;INTRAMUSCULAR, INTRAVENOUS	021337-001	Nov 21, 2001	AP	RX	Yes	Yes

Expired US Patents for Invanz

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Msd Sub Merck	INVANZ	ertapenem sodium	INJECTABLE;INTRAMUSCULAR, INTRAVENOUS	021337-001	Nov 21, 2001
Msd Sub Merck	INVANZ	ertapenem sodium	INJECTABLE;INTRAMUSCULAR, INTRAVENOUS	021337-001	Nov 21, 2001
Msd Sub Merck	INVANZ	ertapenem sodium	INJECTABLE;INTRAMUSCULAR, INTRAVENOUS	021337-001	Nov 21, 2001
Msd Sub Merck	INVANZ	ertapenem sodium	INJECTABLE;INTRAMUSCULAR, INTRAVENOUS	021337-001	Nov 21, 2001

International Patents for Invanz

See the table below for patents covering Invanz around the world.

Country	Patent Number	Title	Estimated Expiration
Australia	3077597
Israel	104588	Carbapenems containing a carboxy substituted phenyl process for their preparation and pharmaceutical compositions containing them
Czech Republic	286878	Carbapenems, process of their preparation, intermediates for their preparation, those carbapenems used for treating infections and pharmaceutical preparations
Austria	173262
Israel	123078	PHARMACEUTICAL COMPOSITIONS CONTAINING CARBAPENEM AND THEIR PREPARATION
Spain	2208907
Georgia, Republic of	P20022694	Carbapenems Containing a Carboxy Substituted Phenyl Group, Processes for Their Preparation, Intermediates and Use as Antibiotics

Supplementary Protection Certificates for Invanz

Patent Number	Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
0579826	SZ 36/2002	Austria		PRODUCT NAME: ERTAPENEM UND ALLE PHARMAZEUTISCH ANNEHMBAREN SALZE DAVON, INSBESONDERE NATRIUM-ERTAPENEM
0579826	C00579826/01	Switzerland		PRODUCT NAME: ERTAPENEM; REGISTRATION NUMBER/DATE: SWISSMEDIC 55902 02.12.2005
0579826	SPC027/2002	Ireland		SPC027/2002: 20040929, EXPIRES: 20170417
0579826	300104	Netherlands		PRODUCT NAME: ERTAPENEM, DESGEWENST IN DE VORM VAN EEN FARMACEUTISCH AANVAARDBAAR ZOUT, IN HET BIJZONDER ERTAPENEMNATRIUM; REGISTRATION NO/DATE: EU/1/02/216/001 20020422
0863901	PA2004008	Lithuania		PRODUCT NAME: ERTAPENEMUM ([4R,5S,6S]-3-[(3S,5S)-5-[(3-KARBOKSIFENIL) AMINO]KARBONIL]-3-PIROLIDINIL]TIO]-6-[(1R)-1HIDROKSIETIL]-4-METIL-7-OKSO-1-AZABICIKLO-[3.2.0]HEPT-2-EN-2-KARBOKSIRUGSTIS; REGISTRATION NO/DATE: 03/8043/3 20030328
0863901	C00863901/01	Switzerland		FORMER OWNER: SCHERING CORPORATION, US
0863901	PA2004008,C0863901	Lithuania		PRODUCT NAME: ERTAPENEMUM ((4R,5S,6S)-3-((3S,5S)-5-((3-KARBOKSIFENIL)AMINO)KARBONIL)-3-PIROLIDINIL)TIO)-6-((1R)-1HIDROKSIETIL)-4-METIL-7-OKSO-1-AZABICIKLO-(3.2.0)HEPT-2-EN-2-KARBOKSIRUGSTIS; REGISTRATION NO/DATE: 03/8043/3 20030328